Key points are not available for this paper at this time.
The results establish atorvastatin as an inhibitor of CYP3A4 activity. Furthermore, 4βHC : C is a useful index of CYP3A4 activity, including the conditions with altered cholesterol concentrations.
Hukkanen et al. (Fri,) studied this question.